Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
NIDDK plans to fund research for collecting, analyzing, and reporting data on human islet transplantation for diabetes, supporting future clinical trial design and public information through the CITR.
Funder: National Institutes of Health
Due Dates: October 1, 2026 (Estimated Application Due Date)
Funding Amounts: $700,000 total program funding; 1 expected award; duration and ceiling not specified
Summary: Supports the collection and analysis of data from clinical trials involving isolated human islets as a treatment for diabetes, with the aim to inform future research and public health.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.
Description
This forthcoming funding opportunity from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will support a collaborative effort to collect and analyze data from clinical trials involving isolated human islets for the treatment of diabetes. The initiative aims to maintain a central registry, facilitate data sharing within the research community, and produce periodic reports on transplantation outcomes and trends. The project will also coordinate regular meetings among participating sites. The primary objective is to enable robust analyses, foster collaborations, and guide the design of future clinical trials in islet transplantation.
